FDA.reportPublic FDA data

tirzepatide 15 MG per dose (60 MG in 2.4 ML) Pen Injector

RxCUI
2734636
RxNorm name
tirzepatide 15 MG per dose (60 MG in 2.4 ML) Pen Injector
Display name
tirzepatide 15 MG per dose (60 MG in 2.4 ML) Pen Injector
Full name
tirzepatide 15 MG per dose (60 MG in 2.4 ML) Pen Injector
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
487cd7e7-434c-4925-99fa-aa80b1cc776btirzepatide 15 MG per dose (60 MG in 2.4 ML) Pen InjectorPSN38These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
487cd7e7-434c-4925-99fa-aa80b1cc776b2.4 ML tirzepatide 25 MG/ML Pen InjectorSCD38These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
487cd7e7-434c-4925-99fa-aa80b1cc776btirzepatide 60 MG per 2.4 ML Pen InjectorSY38These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
d2d7da5d-ad07-4228-955f-cf7e355c8cc0tirzepatide 15 MG per dose (60 MG in 2.4 ML) Pen InjectorPSN38These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
d2d7da5d-ad07-4228-955f-cf7e355c8cc02.4 ML tirzepatide 25 MG/ML Pen InjectorSCD38These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422
d2d7da5d-ad07-4228-955f-cf7e355c8cc0tirzepatide 60 MG per 2.4 ML Pen InjectorSY38These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO. MOUNJARO ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422